|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: BIOCRYST PHARMACEUTICALS INC, 10-Q, EX-10.8, 2000-08-08 |
Next: PHOENIX INVESTMENT PARTNERS LTD/CT, 8-K, 2000-08-08 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
BioCryst Pharmaceuticals, Inc. Financial Statements, and is qualified in its
entirety by reference to such financial statements.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> JUN-30-2000
<CASH> 9,070,140
<SECURITIES> 62,223,936
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 27,147,237
<PP&E> 4,397,495
<DEPRECIATION> 2,220,466
<TOTAL-ASSETS> 74,377,573
<CURRENT-LIABILITIES> 1,522,328
<BONDS> 0
0
0
<COMMON> 175,029
<OTHER-SE> 72,380,216
<TOTAL-LIABILITY-AND-EQUITY> 74,377,573
<SALES> 0
<TOTAL-REVENUES> 6,807,792
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 6,942,228
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 2,070
<INCOME-PRETAX> (136,506)
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (136,506)
<EPS-BASIC> (.01)
<EPS-DILUTED> (.01)
</TABLE>
|
|